A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

Background: Each year in the UK, there are between two and nine deaths from anaphylaxis caused by bee and wasp venom. Anaphylactic reactions can occur rapidly following a sting and can progress to a life-threatening condition within minutes. To avoid further reactions in people with a history of ana...

Full description

Bibliographic Details
Main Authors: J Hockenhull, M Elremeli, MG Cherry, J Mahon, M Lai, J Darroch, J Oyee, A Boland, R Dickson, Y Dundar, R Boyle
Format: Article
Language:English
Published: NIHR Journals Library 2012-03-01
Series:Health Technology Assessment
Subjects:
pharmalgen®
immunotherapy
bee venom
wasp venom
systemic allergic reaction
high-dose antihistamine
adrenaline auto-injector
systematic review
Online Access:https://doi.org/10.3310/hta16120

Internet

https://doi.org/10.3310/hta16120

Similar Items